GB1351409A - Sustained release pharmaceutical compositions for topical appli cation - Google Patents
Sustained release pharmaceutical compositions for topical appli cationInfo
- Publication number
- GB1351409A GB1351409A GB839572A GB839572A GB1351409A GB 1351409 A GB1351409 A GB 1351409A GB 839572 A GB839572 A GB 839572A GB 839572 A GB839572 A GB 839572A GB 1351409 A GB1351409 A GB 1351409A
- Authority
- GB
- United Kingdom
- Prior art keywords
- drug
- sustained release
- polymer
- release pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000013268 sustained release Methods 0.000 title abstract 4
- 239000012730 sustained-release form Substances 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- 150000001768 cations Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 5
- 229940079593 drug Drugs 0.000 abstract 5
- 229920000642 polymer Polymers 0.000 abstract 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000004338 Dichlorodifluoromethane Substances 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000001166 anti-perspirative effect Effects 0.000 abstract 1
- 230000001139 anti-pruritic effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- -1 antiparasatic Substances 0.000 abstract 1
- 239000003213 antiperspirant Substances 0.000 abstract 1
- 239000003908 antipruritic agent Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 230000002254 contraceptive effect Effects 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 239000002781 deodorant agent Substances 0.000 abstract 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 abstract 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008188 pellet Substances 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
- 229920000747 poly(lactic acid) Polymers 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11808171A | 1971-02-23 | 1971-02-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1351409A true GB1351409A (en) | 1974-05-01 |
Family
ID=22376416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB839572A Expired GB1351409A (en) | 1971-02-23 | 1972-02-23 | Sustained release pharmaceutical compositions for topical appli cation |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US3755558A (enExample) |
| CA (1) | CA950828A (enExample) |
| DE (1) | DE2207635A1 (enExample) |
| FR (1) | FR2126270B1 (enExample) |
| GB (1) | GB1351409A (enExample) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0094513A3 (en) * | 1982-05-14 | 1984-08-22 | Akzo Gmbh | Sustained-release body containing an active ingredient |
| US4491575A (en) * | 1982-10-15 | 1985-01-01 | Chemie Linz Aktiengesellschaft | Compressed products with retarded release of active substance, a process for their preparation and a process for the long-term administration of medicaments |
| US4526938A (en) * | 1982-04-22 | 1985-07-02 | Imperial Chemical Industries Plc | Continuous release formulations |
| US4849228A (en) * | 1985-05-07 | 1989-07-18 | Takeda Chemical Industries, Ltd. | Polymer, production and use thereof |
| US5247058A (en) * | 1992-01-24 | 1993-09-21 | Cargill, Incorporated | Continuous process for manufacture of lactide polymers with controlled optical purity |
| US5247059A (en) * | 1992-01-24 | 1993-09-21 | Cargill, Incorporated | Continuous process for the manufacture of a purified lactide from esters of lactic acid |
| US5258488A (en) * | 1992-01-24 | 1993-11-02 | Cargill, Incorporated | Continuous process for manufacture of lactide polymers with controlled optical purity |
| US5274073A (en) * | 1992-01-24 | 1993-12-28 | Cargill, Incorporated | Continuous process for manufacture of a purified lactide |
| US5338822A (en) * | 1992-10-02 | 1994-08-16 | Cargill, Incorporated | Melt-stable lactide polymer composition and process for manufacture thereof |
| US5525706A (en) * | 1992-10-02 | 1996-06-11 | Cargill, Incorporated | Melt-stable lactide polymer nonwoven fabric and process for manufacture thereof |
| US5665474A (en) * | 1992-10-02 | 1997-09-09 | Cargill, Incorporated | Paper having a melt-stable lactide polymer coating and process for manufacture thereof |
| US6005068A (en) * | 1992-10-02 | 1999-12-21 | Cargill Incorporated | Melt-stable amorphous lactide polymer film and process for manufacture thereof |
| US6005067A (en) * | 1992-01-24 | 1999-12-21 | Cargill Incorporated | Continuous process for manufacture of lactide polymers with controlled optical purity |
| US6323307B1 (en) | 1988-08-08 | 2001-11-27 | Cargill Dow Polymers, Llc | Degradation control of environmentally degradable disposable materials |
| US6326458B1 (en) | 1992-01-24 | 2001-12-04 | Cargill, Inc. | Continuous process for the manufacture of lactide and lactide polymers |
| US6528093B1 (en) | 1992-12-07 | 2003-03-04 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
Families Citing this family (103)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3962414A (en) * | 1972-04-27 | 1976-06-08 | Alza Corporation | Structured bioerodible drug delivery device |
| US3914402A (en) * | 1973-06-14 | 1975-10-21 | Alza Corp | Ophthalmic dosage form, for releasing medication over time |
| US4001388A (en) * | 1973-06-14 | 1977-01-04 | Alza Corporation | Ophthalmological bioerodible drug dispensing formulation |
| AR205997A1 (es) * | 1973-11-21 | 1976-06-23 | American Cyanamid Co | Resina de poliester normalmente solida biodegradable e hidrolizable |
| US3960152A (en) * | 1974-01-21 | 1976-06-01 | American Cyanamid Company | Surgical sutures of unsymmetrically substituted 1,4-dioxane-2,5-diones |
| US4076798A (en) * | 1975-05-29 | 1978-02-28 | American Cyanamid Company | High molecular weight polyester resin, the method of making the same and the use thereof as a pharmaceutical composition |
| US4011312A (en) * | 1975-06-25 | 1977-03-08 | American Home Products Corporation | Prolonged release drug form for the treatment of bovine mastitis |
| GB1556710A (en) * | 1975-09-12 | 1979-11-28 | Anic Spa | Method of occluding substances in structures and products obtained thereby |
| US4115544A (en) * | 1976-08-18 | 1978-09-19 | Alza Corporation | Ocular system made of bioerodible esters having linear ether |
| US4328204A (en) * | 1977-03-02 | 1982-05-04 | Ethicon, Inc. | Absorbable polymer-drug compounds and method for making same |
| DE2856901D2 (de) * | 1977-06-07 | 1980-11-13 | Garching Instrumente | Form of implant medicament and preparation process |
| US4186189A (en) * | 1977-09-28 | 1980-01-29 | Ethicon, Inc. | Absorbable pharmaceutical compositions based on poly(alkylene oxalates) |
| US4732763A (en) * | 1978-10-17 | 1988-03-22 | Stolle Research And Development Corporation | Active/passive immunization of the internal female reproductive organs |
| US4585651A (en) * | 1978-10-17 | 1986-04-29 | Stolle Research & Development Corporation | Active/passive immunization of the internal female reproductive organs |
| US4293539A (en) * | 1979-09-12 | 1981-10-06 | Eli Lilly And Company | Controlled release formulations and method of treatment |
| AU534665B2 (en) * | 1979-09-12 | 1984-02-09 | Eli Lilly And Company | Method |
| AU539230B2 (en) * | 1979-09-12 | 1984-09-20 | Eli Lilly And Company | Parasitic formulations and method |
| US5248700A (en) * | 1982-05-14 | 1993-09-28 | Akzo Nv | Active agent containing solid structures for prolonged release of active agents |
| JPS6045522B2 (ja) * | 1982-12-08 | 1985-10-09 | 憲司 中村 | 化粧用具 |
| JPH0798755B2 (ja) * | 1985-11-27 | 1995-10-25 | エチコン・インコ−ポレ−テツド | 局所的投与により術後の癒着形成を抑制するための組成物 |
| IN166447B (enExample) * | 1985-11-27 | 1990-05-12 | Ethicon Inc | |
| CA1297791C (en) * | 1985-12-16 | 1992-03-24 | Warren Douglas Sheffield | Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator |
| US4889722A (en) * | 1985-12-16 | 1989-12-26 | Ethicon, Inc. | Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator |
| EP0234897A3 (en) * | 1986-02-24 | 1987-11-19 | Ethicon, Inc. | Inhibition of post-surgical adhesion formation by the continual topical administration of glucocorticoid |
| DE3620685A1 (de) * | 1986-06-20 | 1987-12-23 | Henkel Kgaa | Neue mittel zur abdeckung unverletzter und/oder verletzter bereiche menschlicher oder tierischer haut |
| US5985354A (en) | 1995-06-07 | 1999-11-16 | Brown University Research Foundation | Preparation of multiwall polymeric microcapsules from hydrophilic polymers |
| DE3734223A1 (de) * | 1987-10-09 | 1989-04-20 | Boehringer Ingelheim Kg | Implantierbares, biologisch abbaubares wirkstofffreigabesystem |
| US5252642A (en) * | 1989-03-01 | 1993-10-12 | Biopak Technology, Ltd. | Degradable impact modified polyactic acid |
| US5216050A (en) * | 1988-08-08 | 1993-06-01 | Biopak Technology, Ltd. | Blends of polyactic acid |
| US5180765A (en) * | 1988-08-08 | 1993-01-19 | Biopak Technology, Ltd. | Biodegradable packaging thermoplastics from lactides |
| US5444113A (en) * | 1988-08-08 | 1995-08-22 | Ecopol, Llc | End use applications of biodegradable polymers |
| US5502158A (en) * | 1988-08-08 | 1996-03-26 | Ecopol, Llc | Degradable polymer composition |
| US5424346A (en) * | 1988-08-08 | 1995-06-13 | Ecopol, Llc | Biodegradable replacement of crystal polystyrene |
| US5725491A (en) * | 1988-10-03 | 1998-03-10 | Atrix Laboratories, Inc. | Method of forming a biodegradable film dressing on tissue |
| US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US5632727A (en) * | 1988-10-03 | 1997-05-27 | Atrix Laboratories, Inc. | Biodegradable film dressing and method for its formation |
| US5633002A (en) * | 1988-10-04 | 1997-05-27 | Boehringer Ingelheim Gmbh | Implantable, biodegradable system for releasing active substance |
| US5487897A (en) | 1989-07-24 | 1996-01-30 | Atrix Laboratories, Inc. | Biodegradable implant precursor |
| USRE37950E1 (en) | 1990-04-24 | 2002-12-31 | Atrix Laboratories | Biogradable in-situ forming implants and methods of producing the same |
| US6353030B1 (en) * | 1990-08-01 | 2002-03-05 | Novartis Ag | Relating to organic compounds |
| DE4112489C2 (de) * | 1991-04-17 | 1994-06-09 | Christian Dr Med Juergens | Verwendung von resorbierbaren, physiologisch unbedenklichen Copolymeren für die topische Behandlung menschlicher oder tierischer Haut |
| EP0509203A3 (en) | 1991-04-17 | 1993-04-14 | Christian Dr. Med. Juergens | Resorbable, physiologically acceptable copolymers and their use |
| DE4229924C2 (de) * | 1991-04-17 | 1995-12-07 | Juergens Christian Dr Med | Verwendung von resorbierbaren Lactidcopolymeren |
| TW247878B (enExample) * | 1991-07-02 | 1995-05-21 | Takeda Pharm Industry Co Ltd | |
| US6013853A (en) * | 1992-02-14 | 2000-01-11 | The University Of Texas System | Continuous release polymeric implant carrier |
| US5876452A (en) * | 1992-02-14 | 1999-03-02 | Board Of Regents, University Of Texas System | Biodegradable implant |
| EP0560014A1 (en) * | 1992-03-12 | 1993-09-15 | Atrix Laboratories, Inc. | Biodegradable film dressing and method for its formation |
| US5576418A (en) * | 1992-06-29 | 1996-11-19 | Jurgens; Christian | Resorbable biocompatible copolymers and their use |
| US5700485A (en) | 1992-09-10 | 1997-12-23 | Children's Medical Center Corporation | Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid |
| US5922340A (en) * | 1992-09-10 | 1999-07-13 | Children's Medical Center Corporation | High load formulations and methods for providing prolonged local anesthesia |
| AU683022B2 (en) * | 1992-09-10 | 1997-10-30 | Children's Medical Center Corporation | Biodegradable polymer matrices for sustained delivery of local anesthetic agents |
| US5714573A (en) * | 1995-01-19 | 1998-02-03 | Cargill, Incorporated | Impact modified melt-stable lactide polymer compositions and processes for manufacture thereof |
| US5618850A (en) * | 1995-03-09 | 1997-04-08 | Focal, Inc. | Hydroxy-acid cosmetics |
| US5722950A (en) * | 1995-06-07 | 1998-03-03 | Atrix Laboratories, Inc. | Method for remote delivery of an aerosolized liquid |
| CN1156961A (zh) | 1995-06-09 | 1997-08-13 | 欧罗赛铁克股份有限公司 | 产生长效局部麻醉的制剂和方法 |
| DE19600095A1 (de) | 1996-01-03 | 1997-07-10 | Christian Dr Med Juergens | Verwendung von Lactidpolymeren zur Adhäsionsprophylaxe |
| WO1997049391A1 (en) | 1996-06-24 | 1997-12-31 | Euro-Celtique, S.A. | Methods for providing safe local anesthesia |
| US5756651A (en) * | 1996-07-17 | 1998-05-26 | Chronopol, Inc. | Impact modified polylactide |
| US6046187A (en) | 1996-09-16 | 2000-04-04 | Children's Medical Center Corporation | Formulations and methods for providing prolonged local anesthesia |
| US5955097A (en) * | 1996-10-18 | 1999-09-21 | Virotex Corporation | Pharmaceutical preparation applicable to mucosal surfaces and body tissues |
| US5858531A (en) * | 1996-10-24 | 1999-01-12 | Bio Syntech | Method for preparation of polymer microparticles free of organic solvent traces |
| US6126919A (en) * | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| US5945126A (en) * | 1997-02-13 | 1999-08-31 | Oakwood Laboratories L.L.C. | Continuous microsphere process |
| KR100367144B1 (ko) | 1997-07-02 | 2003-01-14 | 유로-셀티크 소시에떼 아노뉨 | 관절과 체강(body space)내에서 연장된 마취 |
| US7128927B1 (en) | 1998-04-14 | 2006-10-31 | Qlt Usa, Inc. | Emulsions for in-situ delivery systems |
| US6270802B1 (en) | 1998-10-28 | 2001-08-07 | Oakwood Laboratories L.L.C. | Method and apparatus for formulating microspheres and microcapsules |
| US6143314A (en) * | 1998-10-28 | 2000-11-07 | Atrix Laboratories, Inc. | Controlled release liquid delivery compositions with low initial drug burst |
| DE59910844D1 (de) | 1999-08-18 | 2004-11-18 | Juergens Christian | Resorbierbare Copolylactide und ihre Verwendung |
| US8226598B2 (en) * | 1999-09-24 | 2012-07-24 | Tolmar Therapeutics, Inc. | Coupling syringe system and methods for obtaining a mixed composition |
| CA2685349C (en) * | 1999-11-15 | 2013-09-17 | Bio Syntech Canada Inc. | Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution |
| DK1294414T3 (da) | 2000-06-29 | 2006-07-24 | Biosyntech Canada Inc | Præparat og fremgangsmåde til heling og regenerering af brusk og andre væv |
| ATE322513T1 (de) * | 2000-08-07 | 2006-04-15 | Wako Pure Chem Ind Ltd | Milchsäurepolymer und verfahren zu dessen herstellung |
| DE60125973D1 (de) * | 2000-11-15 | 2007-02-22 | Biosyntech Canada Inc | Verfahren zur wiederherstellung einer geschädigten bandscheibe |
| US20030152637A1 (en) * | 2001-01-25 | 2003-08-14 | Mark Chasin | Local anesthetic, and method of use |
| WO2002100357A1 (en) * | 2001-06-12 | 2002-12-19 | Trial Corporation | Cosmetic |
| TW200526267A (en) | 2001-06-29 | 2005-08-16 | Takeda Chemical Industries Ltd | Controlled release composition and method of producing the same |
| US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
| US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
| US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
| US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US7910641B2 (en) | 2001-10-12 | 2011-03-22 | Monosol Rx, Llc | PH modulated films for delivery of actives |
| US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
| US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
| US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
| US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
| US7264822B2 (en) * | 2002-04-03 | 2007-09-04 | Poly-Med, Inc. | Conjugated drug-polymer coated stent |
| AU2003239175A1 (en) * | 2002-04-24 | 2003-11-10 | Poly-Med, Inc. | Multifaceted endovascular stent coating for preventing restenosis |
| CA2819769C (en) | 2003-07-18 | 2016-06-28 | Oakwood Laboratories, L.L.C. | Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| CA2631431A1 (en) * | 2005-12-27 | 2007-07-05 | Monosol Rx, Llc | Ph modulated films for delivery of actives |
| CN101563068B (zh) * | 2006-12-18 | 2013-03-20 | 武田药品工业株式会社 | 缓释组合物和其制备方法 |
| ES2581837T3 (es) * | 2010-07-26 | 2016-09-07 | Université De Genève | Composiciones que comprenden polímeros preparados a partir de ácidos 2-hidroxi alquil |
| US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
| DE102013209897A1 (de) * | 2013-05-28 | 2014-12-04 | Henkel Ag & Co. Kgaa | Kosmetisches Hautpflegemittel |
| KR20230137362A (ko) | 2016-05-05 | 2023-10-04 | 어퀘스티브 테라퓨틱스, 아이엔씨. | 강화된 전달 에프네프린 조성물 |
| US12427121B2 (en) | 2016-05-05 | 2025-09-30 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| US12433850B2 (en) | 2016-05-05 | 2025-10-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| IT201700058311A1 (it) | 2017-05-29 | 2018-11-29 | Bio Lo Ga Srl | Formulazione a base di vitamina E o di un suo estere per il trattamento di biofilm batterici e fungini |
| US20210196648A1 (en) * | 2019-12-31 | 2021-07-01 | Industrial Technology Research Institute | Drug-containing multilayer film and method for forming the same |
| DE102020215294A1 (de) * | 2020-12-03 | 2022-06-23 | Polymedics Innovations Gmbh | Pflasterzubereitung, Polymerfilm, Sprühpflastersprühvorrichtung, Verfahren zur Herstellung eines Polymerfaservlieses, Polymerfaservlies und Verwendungen der Pflasterzubereitung |
| WO2023076281A1 (en) | 2021-10-25 | 2023-05-04 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
-
1971
- 1971-02-23 US US00118081A patent/US3755558A/en not_active Expired - Lifetime
-
1972
- 1972-02-08 CA CA134,263,A patent/CA950828A/en not_active Expired
- 1972-02-18 DE DE19722207635 patent/DE2207635A1/de not_active Withdrawn
- 1972-02-22 FR FR7205884A patent/FR2126270B1/fr not_active Expired
- 1972-02-23 GB GB839572A patent/GB1351409A/en not_active Expired
Cited By (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4526938A (en) * | 1982-04-22 | 1985-07-02 | Imperial Chemical Industries Plc | Continuous release formulations |
| EP0094513A3 (en) * | 1982-05-14 | 1984-08-22 | Akzo Gmbh | Sustained-release body containing an active ingredient |
| US4491575A (en) * | 1982-10-15 | 1985-01-01 | Chemie Linz Aktiengesellschaft | Compressed products with retarded release of active substance, a process for their preparation and a process for the long-term administration of medicaments |
| US4849228A (en) * | 1985-05-07 | 1989-07-18 | Takeda Chemical Industries, Ltd. | Polymer, production and use thereof |
| US6323307B1 (en) | 1988-08-08 | 2001-11-27 | Cargill Dow Polymers, Llc | Degradation control of environmentally degradable disposable materials |
| US5258488A (en) * | 1992-01-24 | 1993-11-02 | Cargill, Incorporated | Continuous process for manufacture of lactide polymers with controlled optical purity |
| US5247059A (en) * | 1992-01-24 | 1993-09-21 | Cargill, Incorporated | Continuous process for the manufacture of a purified lactide from esters of lactic acid |
| US5274073A (en) * | 1992-01-24 | 1993-12-28 | Cargill, Incorporated | Continuous process for manufacture of a purified lactide |
| US6326458B1 (en) | 1992-01-24 | 2001-12-04 | Cargill, Inc. | Continuous process for the manufacture of lactide and lactide polymers |
| US5357035A (en) * | 1992-01-24 | 1994-10-18 | Cargill, Incorporated | Continuous process for manufacture of lactide polymers with purification by distillation |
| US5247058A (en) * | 1992-01-24 | 1993-09-21 | Cargill, Incorporated | Continuous process for manufacture of lactide polymers with controlled optical purity |
| US6277951B1 (en) | 1992-01-24 | 2001-08-21 | Cargill, Incorporated | Continuous process for manufacture of lactide polymers with controlled optical purity |
| US6005067A (en) * | 1992-01-24 | 1999-12-21 | Cargill Incorporated | Continuous process for manufacture of lactide polymers with controlled optical purity |
| US5773562A (en) * | 1992-10-02 | 1998-06-30 | Cargill, Incorporated | Melt-stable semi-crystalline lactide polymer film and process for manufacture thereof |
| US6093791A (en) * | 1992-10-02 | 2000-07-25 | Cargill, Incorporated | Melt-stable semi-crystalline lactide polymer film and process for manufacture thereof |
| US5665474A (en) * | 1992-10-02 | 1997-09-09 | Cargill, Incorporated | Paper having a melt-stable lactide polymer coating and process for manufacture thereof |
| US5536807A (en) * | 1992-10-02 | 1996-07-16 | Cargill, Incorporated | Melt-stable semi-crystalline lactide polymer film and process for manufacture thereof |
| US5798436A (en) * | 1992-10-02 | 1998-08-25 | Cargill, Incorporated | Melt-stable amorphous lactide polymer film and process for manufacture thereof |
| US5807973A (en) * | 1992-10-02 | 1998-09-15 | Cargill, Incorporated | Melt-stable lactide polymer nonwoven fabric and process for manufacture thereof |
| US5852166A (en) * | 1992-10-02 | 1998-12-22 | Cargill, Incorporated | Paper having a melt-stable lactide polymer coating and process for manufacture thereof |
| US6005068A (en) * | 1992-10-02 | 1999-12-21 | Cargill Incorporated | Melt-stable amorphous lactide polymer film and process for manufacture thereof |
| US5525706A (en) * | 1992-10-02 | 1996-06-11 | Cargill, Incorporated | Melt-stable lactide polymer nonwoven fabric and process for manufacture thereof |
| US5585191A (en) * | 1992-10-02 | 1996-12-17 | Cargill, Incorporated | Melt-stable amorphous lactide polymer film and process for manufacture thereof |
| US6111060A (en) * | 1992-10-02 | 2000-08-29 | Cargill, Incorporated | Melt-stable lactide polymer nonwoven fabric and process for manufacture thereof |
| US6121410A (en) * | 1992-10-02 | 2000-09-19 | Cargill, Incorporated | Melt-stable semi-crystalline lactide polymer film and process for manufacture thereof |
| US6207792B1 (en) | 1992-10-02 | 2001-03-27 | Cargill, Incorporated | Melt-stable amorphous lactide polymer film and process for manufacture thereof |
| US5484881A (en) * | 1992-10-02 | 1996-01-16 | Cargill, Inc. | Melt-stable amorphous lactide polymer film and process for manufacturing thereof |
| US5475080A (en) * | 1992-10-02 | 1995-12-12 | Cargill, Incorporated | Paper having a melt-stable lactide polymer coating and process for manufacture thereof |
| US5338822A (en) * | 1992-10-02 | 1994-08-16 | Cargill, Incorporated | Melt-stable lactide polymer composition and process for manufacture thereof |
| US6355772B1 (en) | 1992-10-02 | 2002-03-12 | Cargill, Incorporated | Melt-stable lactide polymer nonwoven fabric and process for manufacture thereof |
| US6528093B1 (en) | 1992-12-07 | 2003-03-04 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| US7048947B2 (en) | 1992-12-07 | 2006-05-23 | Takeda Pharmaceutical Company Limited | Sustained-release preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2207635A1 (de) | 1972-08-31 |
| US3755558A (en) | 1973-08-28 |
| FR2126270A1 (enExample) | 1972-10-06 |
| CA950828A (en) | 1974-07-09 |
| FR2126270B1 (enExample) | 1975-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1351409A (en) | Sustained release pharmaceutical compositions for topical appli cation | |
| US3876760A (en) | Hair dressing compositions containing a hair substantive quaternary resin | |
| GB1503444A (en) | Non-greasy compositions | |
| GB1310810A (en) | Uv-radiation-absorbing cosmetic compositions | |
| GB1059188A (en) | Colour stable oxytetracycline compositions and process for preparing same | |
| US3627871A (en) | Therapeutic compositions for topical application | |
| US3073743A (en) | Antiinflammatory steroid acetonide compositions and therapy | |
| US4147775A (en) | Antiseptic composition | |
| GB1464388A (en) | Preparations containing microencapsulated substances and process | |
| US2736681A (en) | Chemical compounds | |
| US4411883A (en) | Antiperspirant | |
| US4743441A (en) | Cosmetic composition | |
| US4013792A (en) | Process for the production of base for topical steroids | |
| GB1430324A (en) | Antiacne composition | |
| GB1467947A (en) | Steroid compositions and processes for their preparation | |
| FR2081436B1 (enExample) | ||
| GB1270614A (en) | Stable aqueous steroid phosphate solutions | |
| US3211620A (en) | Stabilized antiperspirant-deodorant composition | |
| GB1481411A (en) | Pharmaceutical compositions | |
| GB1470355A (en) | Pharmaceutical compositions | |
| GB1351903A (en) | Cosmetic and pharmaceutical compositions | |
| IE41417L (en) | Stabilized steroid formulations | |
| GB1488995A (en) | Compositions containing anti-androgenic compounds | |
| GB1468815A (en) | Pharmaceutical compositions | |
| GB1363458A (en) | 6,6-difluoro-3,20-diketo-4-pregnenes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee | ||
| PCNP | Patent ceased through non-payment of renewal fee |